Why Wall Street Wants to Give SmileDirectClub a Second Chance
SmileDirectClub had an absolutely dismal initial public offering, but some analysts say they see very high upside, now that the quiet period has concluded.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 84
Major Step Forward in Peanut Allergy Treatment
DBV Technologies shares dipped on Monday after the firm announced an update from the FDA. Although it was a positive update for the company, this appears to be a case of “sell the news.”
More Good News for LGMD Patients
Sarepta shares jumped on Friday after the firm announced an update from its Duchenne muscular dystrophy trial.
Is the FDA Going Too Soft on Zantac?
The FDA is coming down hard after the disclosure that Zantac and other generic ranitidine drugs could contain impurities and carcinogens.
Plaque Psoriasis Suffers May Have Better Option After Eli Lilly Study
Eli Lilly announced some good news for people suffering moderate to severe plaque psoriasis when it presented at the 5th Annual Maui Derm NP+PA Fall meeting.
Is Vaping as Dangerous as Mustard Gas?
Do the injuries to the patients made ill from vaping resemble those in people exposed to mustard gas? One researcher thinks so.
A Drop in Income Might Scramble Your Brain
That experiencing a decline in income might upset somebody is a no-brainer, but new research suggests that it might literally affect the brain in negative ways.
Health Care Insurance and Health Care REITs See Safety Trade During Market Panic
On days when the main stock market indexes are trading sharply lower, it is interesting to see what stocks and sectors are up on the day.
Johnson & Johnson May Have Just Dodged a Big Opioid Bullet
One analyst issued a fairly bullish report in response to Johnson & Johnson's announcement of a $10 million settlement with two Ohio counties ahead of an upcoming opioid trial.
FDA Accepts for Review the Newest Treatment for C Diff
Merck has just announced that the FDA has accepted a couple new drug applications for review, including for a treatment for Clostridium difficile infections in children.
Baird Has 3 Top Biotech Picks With Huge Upcoming Potential Catalysts
These three biotech stocks have upcoming clinical data and presentations that could be huge, and they could blast the stocks higher.
Would Stryker Be Better Off Buying Conformis?
Conformis shares shot up on Tuesday after the firm announced that it has entered into definitive agreements to sell and license to Stryker to develop, manufacture and supply PSI for use in connection with…
Unusual Settlement Deal Proposed for Opioid Lawsuits
Five drugmakers are considering a proposal that would have them contribute to a trust established as part of the bankruptcy settlement by Purdue Pharmaceuticals and be released from liability in the hundreds of other…
Are Biotechs the Next Target for Cyber Criminals?
Minerva Neurosciences shares dropped sharply on Tuesday after the firm announced that it was the victim of a cyberattack. Minerva also provided an update on its clinical trials.
Major Duchenne Muscular Dystrophy Trial Is Ready to Launch
Catabasis Pharma shares jumped early on Tuesday after the firm announced that it had completed the enrollment for its late-stage Duchenne muscular dystrophy (DMD) study. Specifically, the enrollment is for the Phase 3 PolarisDMD…